1-3 of 3
Noor M Khaskhely, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Histone Deacetylase (HDAC) Inhibitor Entinostat (SNDX-275) Targets Hodgkin Lymphoma through a Dual Mechanism of Immune Modulation and Apoptosis Induction.

Noor M Khaskhely, MD, PhD, Daniela Buglio, MD, Jessica Shafer, MD, Catherine M. Bollard, MD, FRACP, FRCPA, Anas Younes, MD
Journal: Blood
Blood (2009) 114 (22): 1562.
https://doi.org/10.1182/blood.V114.22.1562.1562
Published: 2009
Journal Articles

The Histone Deacetylase Inhibitor MGCD0103 Down Regulates CD30, Activates NF-Kb, and Synergizes with Proteasome Inhibitors by HDAC6 Independent Mechanism in Hodgkin Lymphoma.

Daniela Buglio, MD, Vidya Mamidipudi, Noor M Khaskhely, MD, PhD, Annunziata Gloghini, Antonino Carbone, MD, Carla Heise, Jeffrey M. Besterman, PhD, BSc, Robert E Martell, Kyle J MacBeth, Anas Younes, MD
Journal: Blood
Blood (2009) 114 (22): 3735.
https://doi.org/10.1182/blood.V114.22.3735.3735
Published: 2009
Journal Articles

Differential Effect of the Histone Deacetylase Inhibitors Vorinostat and MGCD0103 in Cell-Free and Cell-Based Assays

Daniela Buglio, MD, Noor M Khaskhely, MD, PhD, George V Georgakis, MD, Anas Younes, MD
Journal: Blood
Blood (2008) 112 (11): 4827.
https://doi.org/10.1182/blood.V112.11.4827.4827
Published: 2008